|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2009-7-16
|
|
pubmed:abstractText |
S-1, an oral fluoropyrimidine, contains tegafur, which is converted to 5-fluorouracil mainly by CYP2A6. We evaluated the association between CYP2A6 polymorphisms and treatment outcome in metastatic gastric cancer patients treated with S-1 plus docetaxel.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1744-8042
|
|
pubmed:author |
pubmed-author:BooksC ACA,
pubmed-author:ChoiIl JuIJ,
pubmed-author:KimNoe KyeongNK,
pubmed-author:KimYoung-WooYW,
pubmed-author:KongSun-YoungSY,
pubmed-author:KookMyeong-CherlMC,
pubmed-author:LeeJun HoJH,
pubmed-author:LimHyeong-SeokHS,
pubmed-author:NamByung-HoBH,
pubmed-author:ParkSook RyunSR,
pubmed-author:ParkYoung-IeeYI,
pubmed-author:RyuKeun WonKW
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1147-55
|
|
pubmed:meshHeading |
pubmed-meshheading:19604090-Adult,
pubmed-meshheading:19604090-Aged,
pubmed-meshheading:19604090-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19604090-Aryl Hydrocarbon Hydroxylases,
pubmed-meshheading:19604090-Drug Combinations,
pubmed-meshheading:19604090-Female,
pubmed-meshheading:19604090-Genome-Wide Association Study,
pubmed-meshheading:19604090-Humans,
pubmed-meshheading:19604090-Male,
pubmed-meshheading:19604090-Middle Aged,
pubmed-meshheading:19604090-Oxonic Acid,
pubmed-meshheading:19604090-Pilot Projects,
pubmed-meshheading:19604090-Polymorphism, Genetic,
pubmed-meshheading:19604090-Stomach Neoplasms,
pubmed-meshheading:19604090-Taxoids,
pubmed-meshheading:19604090-Tegafur,
pubmed-meshheading:19604090-Treatment Outcome,
pubmed-meshheading:19604090-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Association of CYP2A6 polymorphisms with S-1 plus docetaxel therapy outcomes in metastatic gastric cancer.
|
|
pubmed:affiliation |
Research Institute & Hospital, National Cancer Center, Goyang-si, Gyeonggi-do, Republic of Korea.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
